Obstructive Sleep Apnea: Clinical Trials

14 trials for Obstructive Sleep Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting, 2 terminated, 2 unknown. 14 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 114Completed 7, Recruiting 2, Terminated 2, Unknown 2, Withdrawn 1

Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of OSA in Latin American and Response to Neuromod Therapy
Drug Induced Sleep Endoscopy with PNS - Obstructive Sleep Apnea
Early Phase 1RecruitingLunair Medical502024-11-212025-09-03
Time Restricted Eating in Sleep Apnea
Time restricted eating - Time Restricted Eating, Obstructive Sleep Apnea
Early Phase 1RecruitingUniversity of California, San Diego802024-01-052024-01-16
Improving 24-hour Blood Pressure in Obstructive Sleep Apnea
Continuous Positive Airway Pressure CPAP, Telmisartan 80mg, Alpha-Lipoic Acid 600mg - Obstructive Sleep Apnea
Early Phase 1WithdrawnUniversity of British Columbia2023-05-012023-05-19
New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA
Phentolamine Injection - Obstructive Sleep Apnea
Early Phase 1UnknownXu J3502022-04-012023-12-15
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection
Early Phase 1TerminatedThunder Bay Regional Health Research Institute102020-11-102024-10-15
Evaluatation of Appscent Device Safety and Effectiveness for Relief of Obstructive Sleep Apnea (OSA) Syndrome in Adults.
Appscent Device - Obstructive Sleep Apnea
Early Phase 1CompletedY.A. Appscent Ltd.232020-10-152023-01-04
Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery
Hydromorphone, Fentanyl - Obstructive Sleep Apnea, Tonsillitis
Early Phase 1CompletedWashington University School of Medicine1892020-02-262024-12-18
Measurement of Cerebral rSO2 Levels During Sleep in Children With Suspected Obstructive Sleep Apnea
INVOS - Obstructive Sleep Apnea, Pediatric Sleep Apnea
Early Phase 1UnknownTel-Aviv Sourasky Medical Center1002019-09-112020-03-25
Effects of Melatonin in Untreated Obstructive Sleep Apnea
Melatonin, Placebo - Obstructive Sleep Apnea
Early Phase 1TerminatedNaomi Deacon12018-04-012019-01-31
Remifentanil in Children With Obstructive Sleep Apnea
Remifentanil Infusion - Obstructive Sleep Apnea
Early Phase 1CompletedWashington University School of Medicine302015-09-012020-03-12
Promoting Continuous Positive Airway Pressure (CPAP) Adherence
Web-based Access to CPAP Data, Web-based Access to CPAP Data with Financial Incentive - Obstructive Sleep Apnea
Early Phase 1CompletedUniversity of Pennsylvania1352011-09-012014-05-22
The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome
Eszopiclone, Placebo - Obstructive Sleep Apnea
Early Phase 1CompletedBrigham and Women's Hospital172009-01-012017-04-18
Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community
Obstructive sleep apnea screening intervention - Obstructive Sleep Apnea
Early Phase 1CompletedThe University of Texas Health Science Center, Houston1682008-07-012008-12-16
Micro-stream Capnography in Non-intubated Lean and Obese Patients With and Without Obstructive Sleep Apnea
Microcapmicro-stream device with Smart CapnoLine Plus, Microcap micro-stream device with CapnoLine, TG-920 main-stream device (Nihon Kohden, Tokyo, Japan). - Obesity, Obstructive Sleep Apnea
Early Phase 1CompletedThe Cleveland Clinic602006-06-012016-07-20

Narrower conditions

Sleep Apnea, Obstructive (14)  ·  Asbestosis (1)  ·  Asthma (1)  ·  Bronchiectasis (1)  ·  Cystic Fibrosis (1)  ·  Emphysema (1)  ·  Hyperglycemia (1)  ·  Hyperlipidemias (1)  ·  Hypertension, Pulmonary (1)  ·  Intermittent Fasting (1)  ·  Lung Diseases, Interstitial (1)  ·  Lung Neoplasms (1)  ·  Mesothelioma (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)

Broader conditions

Apnea (14)  ·  Dyssomnias (14)  ·  Nervous System Diseases (14)  ·  Respiration Disorders (14)  ·  Respiratory Tract Diseases (14)  ·  Sleep Disorders, Intrinsic (14)  ·  Sleep Wake Disorders (14)  ·  Sleep Apnea Syndromes (13)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Body Weight (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Signs and Symptoms (2)  ·  Adenoma (1)  ·  Behavior (1)

Interventions

Continuous Positive Airway Pressure (1)  ·  Eszopiclone (1)  ·  Fentanyl (1)  ·  Hydromorphone (1)  ·  Melatonin (1)  ·  Nitroglycerin (1)  ·  Phentolamine (1)  ·  Sugars (1)  ·  Sulfur Hexafluoride (1)  ·  Telmisartan (1)  ·  Thioctic Acid (1)  ·  microcrystalline cellulose (1)  ·  perflutren (1)

Sponsors

Washington University School of Medicine (2)  ·  Brigham and Women's Hospital (1)  ·  Lunair Medical (1)  ·  Naomi Deacon (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  The Cleveland Clinic (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Thunder Bay Regional Health Research Institute (1)  ·  University of British Columbia (1)  ·  University of California, San Diego (1)  ·  University of Pennsylvania (1)  ·  Xu J (1)  ·  Y.A. Appscent Ltd. (1)

Countries

United States (7)  ·  Israel (2)  ·  Canada (1)  ·  China (1)  ·  Paraguay (1)

Top investigators

Anshuman Sharma, MD (1)  ·  Ari Derowe, prof (1)  ·  Atul Malhotra, MD (1)  ·  Kevin O Hwang, MD, MPH (1)  ·  Michael Montana, MD PhD (1)  ·  Mitchell S Albert, PhD (1)  ·  Naomi L Deacon, Ph.D. (1)  ·  Omar Mesarwi, MD (1)  ·  Samuel T Kuna, MD (1)  ·  Yusuke Kasuya, MD, PhD (1)

Results publications

PMID 20974339, PMID 21269278, PMID 21539679, PMID 22926176, PMID 35584850, PMID 35762891, PMID 42312422

NIH funding

P01HL095491 (1), RC2AG036592 (1), UL1TR002345 (1)